Status:
RECRUITING
Adapted Physical Activity for Children Treated With Cancer and Insulin Sensitivity
Lead Sponsor:
University Hospital, Toulouse
Conditions:
Pediatric Cancer
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The main objective of this study is to evaluate the evolution of the sensitivity to insulin, a hormone that acts on sugar in the body, as well as other metabolic, motor and nutritional elements of chi...
Detailed Description
The protocol consists of 6 months of intense physical activity and stretching programs for children with solid cancer or haematological disease, starting at diagnosis. Evaluations will be performed at...
Eligibility Criteria
Inclusion
- age between 5 and 18 years old;
- have a solid cancer or hematological disease;
- be treated for the first time in pediatric oncology and hematology department;
- have an estimated life expectancy at diagnosis of more than 6 months.
Exclusion
- present a physical and/or psychological impossibility to follow an adapted physical activity program;
- have a pre-existing heart disease that is not suitable for adapted physical activities;
- have a known type 1 diabetes
- have an obesity defined by a body mass index greater than or equal to the International Obesity Task Force 25 threshold
Key Trial Info
Start Date :
July 11 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT05383092
Start Date
July 11 2022
End Date
December 31 2026
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PASQUET Marlène
Toulouse, France, 31